Literature DB >> 20974231

GABAergic transmission modulates ethanol excitation of ventral tegmental area dopamine neurons.

J W Theile1, H Morikawa, R A Gonzales, R A Morrisett.   

Abstract

Activation of the dopaminergic (DA) neurons of the ventral tegmental area (VTA) by ethanol has been implicated in its rewarding and reinforcing effects. We previously demonstrated that ethanol enhances GABA release onto VTA-DA neurons via activation of 5-HT2C receptors and subsequent release of calcium from intracellular stores. Here we demonstrate that excitation of VTA-DA neurons by ethanol is limited by an ethanol-enhancement in GABA release. In this study, we performed whole-cell voltage clamp recordings of miniature inhibitory postsynaptic currents (mIPSCs) and cell-attached recordings of action potential firing from VTA-DA neurons in midbrain slices from young Long Evans rats. Acute exposure to ethanol (75 mM) transiently enhanced the firing rate of VTA-DA neurons as well as the frequency of mIPSCs. Simultaneous blockade of both GABA(A) and GABA(B) receptors (Picrotoxin (75 μM) and SCH50911 (20 μM)) disinhibited VTA-DA firing rate whereas a GABA(A) agonist (muscimol, 1 μM) strongly inhibited firing rate. In the presence of picrotoxin, ethanol enhanced VTA-DA firing rate more than in the absence of picrotoxin. Additionally, a sub-maximal concentration of muscimol together with ethanol inhibited VTA-DA firing rate more than muscimol alone. DAMGO (3 μM) inhibited mIPSC frequency but did not block the ethanol-enhancement in mIPSC frequency. DAMGO (1 and 3 μM) had no effect on VTA-DA firing rate. Naltrexone (60 μM) had no effect on basal or ethanol-enhancement of mIPSC frequency. Additionally, naltrexone (20 and 60 μM) did not block the ethanol-enhancement in VTA-DA firing rate. Overall, the present results indicate that the ethanol enhancement in GABA release onto VTA-DA neurons limits the stimulatory effect of ethanol on VTA-DA neuron activity and may have implications for the rewarding properties of ethanol. Copyright Â
© 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974231      PMCID: PMC3010434          DOI: 10.1016/j.neuroscience.2010.10.046

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  48 in total

1.  GABA(A) receptors in the ventral tegmental area control bidirectional reward signalling between dopaminergic and non-dopaminergic neural motivational systems.

Authors:  S R Laviolette; D van der Kooy
Journal:  Eur J Neurosci       Date:  2001-03       Impact factor: 3.386

2.  Dopaminergic neurons in the ventral tegmental area of C57BL/6J and DBA/2J mice differ in sensitivity to ethanol excitation.

Authors:  M S Brodie; S B Appel
Journal:  Alcohol Clin Exp Res       Date:  2000-07       Impact factor: 3.455

3.  Contingent and non-contingent effects of low-dose ethanol on GABA neuron activity in the ventral tegmental area.

Authors:  Scott C Steffensen; Christine H Walton; David M Hansen; Jordan T Yorgason; Roger A Gallegos; Jose R Criado
Journal:  Pharmacol Biochem Behav       Date:  2008-10-29       Impact factor: 3.533

4.  Mu-opioid receptors selectively regulate basal inhibitory transmission in the central amygdala: lack of ethanol interactions.

Authors:  Maeng-Hee Kang-Park; Brigitte L Kieffer; Amanda J Roberts; Marisa Roberto; Samuel G Madamba; George Robert Siggins; Scott D Moore
Journal:  J Pharmacol Exp Ther       Date:  2008-10-14       Impact factor: 4.030

5.  Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms.

Authors:  V I Chefer; L Denoroy; A Zapata; T S Shippenberg
Journal:  Eur J Neurosci       Date:  2009-07-15       Impact factor: 3.386

6.  Role of 5-hydroxytryptamine2C receptors in Ca2+-dependent ethanol potentiation of GABA release onto ventral tegmental area dopamine neurons.

Authors:  Jonathan W Theile; Hitoshi Morikawa; Rueben A Gonzales; Richard A Morrisett
Journal:  J Pharmacol Exp Ther       Date:  2009-02-18       Impact factor: 4.030

7.  Brain regional differences in the effect of ethanol on GABA release from presynaptic terminals.

Authors:  Hugh E Criswell; Zhen Ming; M Katherine Kelm; George R Breese
Journal:  J Pharmacol Exp Ther       Date:  2008-05-23       Impact factor: 4.030

8.  The shell of the nucleus accumbens has a higher dopamine response compared with the core after non-contingent intravenous ethanol administration.

Authors:  E C Howard; C J Schier; J S Wetzel; C L Duvauchelle; R A Gonzales
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

9.  Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats.

Authors:  Miriam Melis; Giuliano Pillolla; Simona Perra; Giancarlo Colombo; Anna Lisa Muntoni; Marco Pistis
Journal:  Psychopharmacology (Berl)       Date:  2008-09-06       Impact factor: 4.530

10.  Effect of acute ethanol administration on the release of opioid peptides from the midbrain including the ventral tegmental area.

Authors:  Samuel Jarjour; Li Bai; Christina Gianoulakis
Journal:  Alcohol Clin Exp Res       Date:  2009-03-19       Impact factor: 3.455

View more
  35 in total

1.  The Cerebellar GABAAR System as a Potential Target for Treating Alcohol Use Disorder.

Authors:  David J Rossi; Ben D Richardson
Journal:  Handb Exp Pharmacol       Date:  2018

Review 2.  Circadian clock genes: effects on dopamine, reward and addiction.

Authors:  Puja K Parekh; Angela R Ozburn; Colleen A McClung
Journal:  Alcohol       Date:  2015-01-08       Impact factor: 2.405

3.  Histone deacetylase inhibition reduces ventral tegmental area dopamine neuronal hyperexcitability involving AKAP150 signaling following maternal deprivation in juvenile male rats.

Authors:  Ryan D Shepard; Ludovic D Langlois; Michael E Authement; Fereshteh S Nugent
Journal:  J Neurosci Res       Date:  2020-03-11       Impact factor: 4.164

4.  GIRK3 gates activation of the mesolimbic dopaminergic pathway by ethanol.

Authors:  Melissa A Herman; Harpreet Sidhu; David G Stouffer; Max Kreifeldt; David Le; Chelsea Cates-Gatto; Michaelanne B Munoz; Amanda J Roberts; Loren H Parsons; Marisa Roberto; Kevin Wickman; Paul A Slesinger; Candice Contet
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

5.  Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?

Authors:  Kenneth Blum; Thomas J H Chen; John Bailey; Abdalla Bowirrat; John Femino; Amanda L C Chen; Thomas Simpatico; Siobhan Morse; John Giordano; Uma Damle; Mallory Kerner; Eric R Braverman; Frank Fornari; B William Downs; Cynthia Rector; Debmayla Barh; Marlene Oscar-Berman
Journal:  Mol Neurobiol       Date:  2011-09-24       Impact factor: 5.590

6.  Opposing actions of CRF-R1 and CB1 receptors on VTA-GABAergic plasticity following chronic exposure to ethanol.

Authors:  Benjamin A Harlan; Howard C Becker; John J Woodward; Arthur C Riegel
Journal:  Neuropsychopharmacology       Date:  2018-06-09       Impact factor: 7.853

7.  Modulation of ethanol reward sensitivity by nicotinic acetylcholine receptors containing the α6 subunit.

Authors:  Melissa J Guildford; Anthony V Sacino; Andrew R Tapper
Journal:  Alcohol       Date:  2016-10-08       Impact factor: 2.405

Review 8.  Identifying the role of pre-and postsynaptic GABA(B) receptors in behavior.

Authors:  Chelsea R Kasten; Stephen L Boehm
Journal:  Neurosci Biobehav Rev       Date:  2015-08-15       Impact factor: 8.989

9.  Contribution of synchronized GABAergic neurons to dopaminergic neuron firing and bursting.

Authors:  Ekaterina O Morozova; Maxym Myroshnychenko; Denis Zakharov; Matteo di Volo; Boris Gutkin; Christopher C Lapish; Alexey Kuznetsov
Journal:  J Neurophysiol       Date:  2016-07-20       Impact factor: 2.714

10.  Alcohol effects on synaptic transmission in periaqueductal gray dopamine neurons.

Authors:  Chia Li; Nora M McCall; Alberto J Lopez; Thomas L Kash
Journal:  Alcohol       Date:  2013-04-15       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.